San Francisco, CA – February 2021 EnGen Bio is an early stage biotechnology company pioneering a new approach to preventing and treating influenza, with the goal of an effective, easy-to-manufacture, shelf-stable universal flu vaccine that should confer long-term immunity to all Type…

As the world still holds its breath for the widespread rollout of COVID-19 vaccines, the experts studying infectious diseases are already shifting their focus to the prevention of the next pandemic. While this may seem pessimistic to those eager to celebrate the…